Directors' Interest in Shares

13 Mar 2008 12:26

Oxford Biomedica PLC13 March 2008 For Immediate Release 13 March 2008 Oxford BioMedica plc ("the Company") Directors' Interest in Shares and Share Options Oxford BioMedica (OXB:L) The Company today announced that on 13 March 2008 thefollowing awards under the Oxford BioMedica plc Long Term Incentive Plan (LTIP)were made to six executive directors. LTIP: Total shares Percentage of number of over which issued shares shares options are under option awarded held (note 1) Alan Kingsman 1,291,871 2,605,404 0.49%Susan Kingsman 565,640 1,643,331 0.31%Michael McDonald 1,017,542 3,087,843 0.57%Andrew Wood 977,533 2,384,974 0.44%Peter Nolan 771,400 1,612,355 0.30%Nick Woolf 788,582 2,434,867 0.45% Note 1: The total shares over which options are held (share options grantedbetween April 2001 and September 2006 and LTIPs awarded since March 2007)following the awards described above. The share price on which the awards were calculated was 22.5p (the closing priceon the day preceding the awards). The LTIP awards are nil-cost options. The LTIPawards are subject to a three year holding period, and are exercisable on thethird anniversary of the award, subject to the satisfaction of a TotalShareholder Return (TSR) performance condition described below. No awards will be released at the testing date for less than median performanceof Oxford BioMedica TSR compared to a comparator group made up of 20 companiesfrom the biotechnology and healthcare sectors. Median performance will result inrelease of 25% of the shares. Upper quartile performance (i.e. greater than 75thpercentile performance) will result in release of 100% of the shares, withstraight line release between these points. If the performance conditions arenot satisfied or partially satisfied at the end of the holding period, the LTIPaward or the balance of the award (as appropriate) not released shall lapse.There will be no re-testing of the performance conditions. Andrew Wood Company Secretary, Oxford BioMedica plc 13 March 2008 This information is provided by RNS The company news service from the London Stock Exchange